Drug intelligence / Profile preview

Apple pectin

Development stage: Preclinical
Lead developer: Lanzhou Science and Technology Plan fund
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Apple pectin is a complex polysaccharide and soluble dietary fiber extracted from apples. It is not absorbed by the body but exerts its effects within the gastrointestinal tract. As a dietary fiber, it forms a gel-like substance that can increase feelings of satiety, slow gastric emptying, and reduce the absorption of fats and sugars, thereby aiding in weight management and blood sugar control. Apple pectin also functions as a prebiotic, promoting the growth of beneficial gut bacteria. Fermentation of pectin by the gut microbiota produces short-chain fatty acids (SCFAs), such as butyrate, acetate, and propionate. These SCFAs contribute to gut health, modulate the immune system, and may help alleviate obesity and related metabolic disorders. A clinical trial is investigating its effects on metabolically associated fatty liver disease.

Beyond the preview

Go deeper on Apple pectin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apple pectin.

Explore the full profile